CVE-2025-9430

Public Exploit
mtons mblog update cross site scripting

Description

A vulnerability was detected in mtons mblog up to 3.5.0. This issue affects some unknown processing of the file /admin/options/update. The manipulation of the argument input results in cross site scripting. It is possible to launch the attack remotely. The exploit is now public and may be used.

Category

4.8
CVSS
Severity: Medium
CVSS 4.0 •
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.03%
Third-Party Advisory vuldb.com Third-Party Advisory vuldb.com
Affected: mtons mblog
Published at:
Updated at:

References

Link Tags
https://vuldb.com/?id.321271 vdb entry technical description third party advisory
https://vuldb.com/?ctiid.321271 vdb entry permissions required signature
https://vuldb.com/?submit.634156 vdb entry third party advisory
https://gitee.com/mtons/mblog/issues/ICPMMF exploit issue tracking

Frequently Asked Questions

What is the severity of CVE-2025-9430?
CVE-2025-9430 has been scored as a medium severity vulnerability.
How to fix CVE-2025-9430?
To fix CVE-2025-9430, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2025-9430 being actively exploited in the wild?
It is possible that CVE-2025-9430 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2025-9430?
CVE-2025-9430 affects mtons mblog.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.